Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis

V Nicosia1, Giorgio Colombo2, M Consentino1, S Di Matteo2, F Mika1, S De Sanctis1, S Ratti2, Marta Vinci21Saipem Medical Dept. San Donato Milanese, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche, Milano, ItalyObjective: International travelers from non-endemic areas are at high risk of contra...

Full description

Bibliographic Details
Main Authors:	V Nicosia, Giorgio Colombo, M Consentino, S Di Matteo, F Mika, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-09-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/assessment-of-acceptability-and-ease-of-use-of-atovaquoneproguanil-med-a2127

Similar Items

Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
by: McKeage, K, et al.
Published: (2003)

The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
by: Enosse, S, et al.
Published: (2000)

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
by: Mcgready, R, et al.
Published: (2003)

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis
by: Ivanovic Jelena, et al.
Published: (2011-05-01)

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
by: van Vugt, M, et al.
Published: (2002)

Absence of an interaction between artesunate and atovaquone--proguanil.
by: van Vugt, M, et al.
Published: (1999)

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
by: Färnert, A, et al.
Published: (2003)

Tolerability of Atovaquone—Proguanil Application in Common Buzzard Nestlings
by: Anja Wiegmann, et al.
Published: (2022-07-01)

Inhibition of the mosquito transmission of Plasmodium berghei by Malarone (atovaquone-proguanil).
by: Butcher, G, et al.
Published: (2000)

A survey on outcomes of accidental atovaquone–proguanil exposure in pregnancy
by: Kathrine R. Tan, et al.
Published: (2018-05-01)

Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
by: Gupta, R, et al.
Published: (2005)

Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
by: Lacy, MD, et al.
Published: (2002)

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
by: Maude, R, et al.
Published: (2014)

Early treatment failure during treatment of <it>Plasmodium falciparum</it> malaria with atovaquone-proguanil in the Republic of Ivory Coast
by: Wurtz Nathalie, et al.
Published: (2012-05-01)

A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.
by: Miriam K Laufer, et al.
Published: (2012-01-01)

Atovaquone and proguanil hydrochloride compared with chloroquine or pyrimethamine/sulfadoxine for treatment of acute Plasmodium falciparum malaria in Peru
by: A. Llanos-Cuentas, et al.

Atovaquone and proguanil hydrochloride compared with chloroquine or pyrimethamine/sulfadoxine for treatment of acute Plasmodium falciparum malaria in Peru
by: Llanos-Cuentas A., et al.
Published: (2001-01-01)

A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
by: Mcgready, R, et al.
Published: (2005)

Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
by: Mcgready, R, et al.
Published: (2003)

Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.
by: Beatrix Huei-Yi Teo, et al.
Published: (2015-01-01)

Mutations in the <it>Plasmodium falciparum cytochrome b </it>gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
by: Fivelman Quinton L, et al.
Published: (2008-11-01)

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
by: Rahul P. Bakshi, et al.
Published: (2018-01-01)

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis
by: Staines, H, et al.
Published: (2017)

Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
by: Ling, J, et al.
Published: (2002)

Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (malarone) when taken as chemoprophylaxis
by: Mita, T, et al.
Published: (2003)

Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis.
by: Thapar, M, et al.
Published: (2002)

Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis
by: Mita, T, et al.
Published: (2003)

Proguanil and atovaquone use is associated with lower colorectal cancer risk: a nationwide cohort study
by: Naiqi Zhang, et al.
Published: (2022-11-01)

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed <it>Plasmodium falciparum </it>isolates from Africa
by: Kyle Dennis E, et al.
Published: (2006-10-01)

Detection of atovaquone-proguanil resistance conferring mutations in <it>Plasmodium falciparum </it>cytochrome b gene in Luanda, Angola
by: Varandas Luís, et al.
Published: (2006-04-01)

<it>In vitro </it>atovaquone/proguanil susceptibility and characterization of the <it>cytochrome b </it>gene of <it>Plasmodium falciparum </it>from different endemic regions of Thailand
by: Mungthin Mathirut, et al.
Published: (2008-01-01)

A Safe and Effective Atovaquone-Proguanil Therapeutic Protocol for the Treatment of Avian Malaria by <i>Plasmodium relictum</i> in Snowy Owl (<i>Bubo scandiacus</i>)
by: Nicola Pugliese, et al.
Published: (2023-11-01)

Superior protection in a relapsing Plasmodium cynomolgi rhesus macaque model by a chemoprophylaxis with sporozoite immunization regimen with atovaquone-proguanil followed by primaquine
by: Kosol Yongvanitchit, et al.
Published: (2024-04-01)

Estudo comparativo entre uma combinação de atovaquone mais proguanil e um regime de quinino mais tetraciclina no tratamento de malária aguda por Plasmodium falciparum em adultos no Brasil
by: Filomena Euridice Carvalho de Alencar
Published: (1999-04-01)

Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.
by: Wattanagoon, Y, et al.
Published: (1987)

Simultaneous quantitation of the highly lipophilic atovaquone and hydrophilic strong basic proguanil and its metabolites using a new mixed-mode SPE approach and steep-gradient LC.
by: Lindegårdh, N, et al.
Published: (2005)

Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria.
by: Chiodini, P, et al.
Published: (1995)

Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
by: Krudsood, S, et al.
Published: (2005)

Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil
by: JP Dean Goldring, et al.
Published: (1999-09-01)

Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito
by: Victoria A. Balta, et al.
Published: (2023-10-01)